Enliven Therapeutics (ELVN) Other Working Capital Changes (2019)

Enliven Therapeutics (ELVN) posted Other Working Capital Changes of -$369000.0 for Q4 2019.

Enliven Therapeutics (ELVN) Other Working Capital Changes (2019) Analysis & Trends

Enliven Therapeutics has reported Other Working Capital Changes for 1 years, with the latest figure at -$369000.0 in Q4 2019.

  • Quarterly Other Working Capital Changes fell 40.58% year-over-year to -$97000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$365000.0 (down 13.71% YoY) and the FY2025 annual result came in at -$337000.0, down 0.6% from the prior year.
  • Other Working Capital Changes eased to -$97000.0 in Q1 2026 per ELVN's latest filing, from -$91000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $1000.0 in Q4 2022 and troughed at -$229000.0 in Q3 2023.
  • A 5-year average of -$77000.0 and a median of -$83500.0 in 2024 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 63.32% in 2024, down 8200.0% in 2024.
  • Over 5 years, Other Working Capital Changes stood at $1000.0 in 2022, then plunged by 8000.0% to -$79000.0 in 2023, then declined by 7.59% to -$85000.0 in 2024, then decreased by 7.06% to -$91000.0 in 2025, then slipped by 6.59% to -$97000.0 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$97000.0, -$91000.0, and -$90000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Enliven Therapeutics 4.31 Bn 3.41 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2019 -369,000.00
Dec 31, 2019 -369,000.00
Dec 31, 2019 -369,000.00